Capital Fund Management (CFM)’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,400
Closed -$856K 2017
2025
Q4
$856K Sell
42,400
-300
-0.7% -$7.26K ﹤0.01% 2070
2025
Q3
$1.29M Hold
42,700
﹤0.01% 1984
2025
Q2
$552K Hold
42,700
﹤0.01% 2173
2025
Q1
$311K Sell
42,700
-76,100
-64% -$842K ﹤0.01% 1905
2024
Q4
$1.98M Sell
118,800
-12,500
-10% -$167K 0.01% 1492
2024
Q3
$1.69M Sell
131,300
-34,600
-21% -$500K ﹤0.01% 1513
2024
Q2
$1.85M Sell
165,900
-35,900
-18% -$418K 0.01% 1416
2024
Q1
$2.5M Buy
201,800
+91,400
+83% +$1.52M 0.01% 1348
2023
Q4
$2.93M Buy
110,400
+20,900
+23% +$610K 0.01% 1347
2023
Q3
$4.09M Buy
89,500
+26,600
+42% +$1.23M 0.01% 1044
2023
Q2
$2.59M Buy
+62,900
New +$2.06M 0.01% 1100

Other funds holding AEHR

Capital Fund Management (CFM)'s AEHR Position: Q4 2023 in Review

Capital Fund Management (CFM) sold out of Aehr Test Systems (AEHR) in Q4 2023, closing a stake of 94,725 shares — an estimated $2.76M sold.

Capital Fund Management (CFM) first reported a position in AEHR in Q4 2021 and held it in 4 quarters. The position peaked at $5.42M in Q4 2021. 168 funds tracked by Wall St. Rank hold AEHR as of Q4 2023.

  • Capital Fund Management (CFM) reported no remaining Aehr Test Systems position as of Q4 2023 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 94,725 Aehr Test Systems shares in Q4 2023, an estimated $2.76M.
  • Capital Fund Management (CFM) first reported a position in Aehr Test Systems in Q4 2021 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s Aehr Test Systems position peaked at $5.42M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2023, filed 14 Feb 2024.